James K Y Hooi1, Wan Ying Lai1, Wee Khoon Ng2, Michael M Y Suen1, Fox E Underwood3, Divine Tanyingoh3, Peter Malfertheiner4, David Y Graham5, Vincent W S Wong1, Justin C Y Wu1, Francis K L Chan1, Joseph J Y Sung1, Gilaad G Kaplan6, Siew C Ng7. 1. Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, LKS Institute of Health Science, Chinese University of Hong Kong, Hong Kong, China. 2. Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, LKS Institute of Health Science, Chinese University of Hong Kong, Hong Kong, China; Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore. 3. Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. 4. Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University of Magdeburg, Magdeburg, Germany. 5. Gastroenterology, Baylor College of Medicine, Houston, Texas. 6. Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address: ggkaplan@ucalgary.ca. 7. Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, LKS Institute of Health Science, Chinese University of Hong Kong, Hong Kong, China. Electronic address: siewchienng@cuhk.edu.hk.
Abstract
BACKGROUND & AIMS: The epidemiology of Helicobacter pylori infection has changed with improvements in sanitation and methods of eradication. We performed a systematic review and meta-analysis to evaluate changes in the global prevalence of H pylori infection. METHODS: We performed a systematic search of the MEDLINE and EMBASE databases for studies of the prevalence of H pylori infection published from January 1, 1970 through January 1, 2016. We analyzed data based on United Nations geoscheme regions and individual countries. We used a random effects model to calculate pooled prevalence estimates with 95% confidence intervals (CIs), weighted by study size. We extrapolated 2015 prevalence estimates to obtain the estimated number of individuals with H pylori infection. RESULTS: Among 14,006 reports screened, we identified 263 full-text articles on the prevalence of H pylori infection; 184 were included in the final analysis, comprising data from 62 countries. Africa had the highest pooled prevalence of H pylori infection (70.1%; 95% CI, 62.6-77.7), whereas Oceania had the lowest prevalence (24.4%; 95% CI, 18.5-30.4). Among individual countries, the prevalence of H pylori infection varied from as low as 18.9% in Switzerland (95% CI, 13.1-24.7) to 87.7% in Nigeria (95% CI, 83.1-92.2). Based on regional prevalence estimates, there were approximately 4.4 billion individuals with H pylori infection worldwide in 2015. CONCLUSIONS: In a systematic review and meta-analysis to assess the prevalence of H pylori infection worldwide, we observed large amounts of variation among regions-more than half the world's population is infected. These data can be used in development of customized strategies for the global eradication.
BACKGROUND & AIMS: The epidemiology of Helicobacter pylori infection has changed with improvements in sanitation and methods of eradication. We performed a systematic review and meta-analysis to evaluate changes in the global prevalence of H pylori infection. METHODS: We performed a systematic search of the MEDLINE and EMBASE databases for studies of the prevalence of H pylori infection published from January 1, 1970 through January 1, 2016. We analyzed data based on United Nations geoscheme regions and individual countries. We used a random effects model to calculate pooled prevalence estimates with 95% confidence intervals (CIs), weighted by study size. We extrapolated 2015 prevalence estimates to obtain the estimated number of individuals with H pylori infection. RESULTS: Among 14,006 reports screened, we identified 263 full-text articles on the prevalence of H pylori infection; 184 were included in the final analysis, comprising data from 62 countries. Africa had the highest pooled prevalence of H pylori infection (70.1%; 95% CI, 62.6-77.7), whereas Oceania had the lowest prevalence (24.4%; 95% CI, 18.5-30.4). Among individual countries, the prevalence of H pylori infection varied from as low as 18.9% in Switzerland (95% CI, 13.1-24.7) to 87.7% in Nigeria (95% CI, 83.1-92.2). Based on regional prevalence estimates, there were approximately 4.4 billion individuals with H pylori infection worldwide in 2015. CONCLUSIONS: In a systematic review and meta-analysis to assess the prevalence of H pylori infection worldwide, we observed large amounts of variation among regions-more than half the world's population is infected. These data can be used in development of customized strategies for the global eradication.
Authors: Benjamin D Hallowell; Meheret Endeshaw; Matthew T McKenna; Virginia Senkomago; Hilda Razzaghi; Mona Saraiya Journal: Prev Med Date: 2019-06-18 Impact factor: 4.018
Authors: Johanna C Sierra; Giovanni Suarez; M Blanca Piazuelo; Paula B Luis; Dara R Baker; Judith Romero-Gallo; Daniel P Barry; Claus Schneider; Douglas R Morgan; Richard M Peek; Alain P Gobert; Keith T Wilson Journal: Proc Natl Acad Sci U S A Date: 2019-02-25 Impact factor: 11.205
Authors: Adam Tepler; Neeraj Narula; Richard M Peek; Anish Patel; Cyrus Edelson; Jean-Frederic Colombel; Shailja C Shah Journal: Aliment Pharmacol Ther Date: 2019-06-05 Impact factor: 8.171
Authors: Shria Kumar; David C Metz; Gregory G Ginsberg; David E Kaplan; David S Goldberg Journal: Aliment Pharmacol Ther Date: 2020-03-04 Impact factor: 8.171
Authors: Mariana I Capurro; Laura K Greenfield; Akriti Prashar; Sunny Xia; Majd Abdullah; Harikesh Wong; Xi Zoe Zhong; Nina Bertaux-Skeirik; Jayati Chakrabarti; Iram Siddiqui; Catherine O'Brien; Xianping Dong; Lisa Robinson; Richard M Peek; Dana J Philpott; Yana Zavros; Michael Helmrath; Nicola L Jones Journal: Nat Microbiol Date: 2019-05-20 Impact factor: 17.745
Authors: Jennifer M Noto; Kristie L Rose; Amanda J Hachey; Alberto G Delgado; Judith Romero-Gallo; Lydia E Wroblewski; Barbara G Schneider; Shailja C Shah; Timothy L Cover; Keith T Wilson; Dawn A Israel; Juan Carlos Roa; Kevin L Schey; Yana Zavros; M Blanca Piazuelo; Richard M Peek Journal: Mol Cell Proteomics Date: 2018-11-19 Impact factor: 5.911